v3.22.2.2
Balance Sheet
Dec. 31, 2021
USD ($)
ASSETS  
Current asset - cash $ 2,164
Deferred offering costs 287,601
Total Assets 289,765
Current Liabilities  
Accrued expenses 151,503
Promissory note – related party 133,357
Total Current Liabilities 284,860
Commitments and Contingencies
Stockholders’ Equity  
Preferred shares, $0.000001 par value; 1,000,000 shares authorized; none issued and outstanding
Common stock, par value $0.000001; 100,000,000 shares authorized; 2,875,000 issued and outstanding 3 [1]
Additional paid-in capital 24,997
Accumulated deficit (20,095)
Total Stockholders’ Equity 4,905
Total Liabilities and Stockholders’ Equity $ 289,765
[1] Includes an aggregate of 375,000 shares of common stock subject to forfeiture to the extent that the underwriters’ over-allotment is not exercised in full or in part. On February 10, 2022, the underwriters partially exercised the over-allotment option and purchased an additional 159,069 units and forfeited the remainder of the option, meaning 335,233 shares of common stock were forfeited.